Gavin MacBeath insider trades
Open-market stock purchases and sales by Gavin MacBeath, Chief Executive Officer at TScan Therapeutics, Inc, from SEC Form 4 filings since Sep 20, 2021.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -84%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 20, 2026 | TCRX TScan Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TCRX TScan Therapeutics, Inc: 2 buys, last Jan 20, 2026